LifeShare Blood Centers FDA Inspection Record

FEI 2377737 · Inspections, Form 483s, warning letters and import refusals

LifeShare Blood Centers is an FDA-inspected facility (FEI 2377737) located in Lake Charles, LA, US. RegDataLab tracks 6 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Apr 4, 2023: No Action Indicated (NAI)
Inspections on record
6 (6 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
12, latest Dec 4, 2024

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Apr 4, 2023No Action Indicated (NAI)No citations listed
Oct 18, 2017No Action Indicated (NAI)No citations listed
Sep 8, 2016No Action Indicated (NAI)No citations listed
Oct 30, 2014No Action Indicated (NAI)No citations listed
Dec 19, 2012No Action Indicated (NAI)No citations listed
Dec 4, 2008No Action Indicated (NAI)No citations listed

Recalls

Showing the 10 most recent of 12 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Dec 4, 2024Class IIIB-0154-2025Red Blood Cells, Leukocytes Reduced
Leukoreduced Red Blood Cells, collected from a donor who lacked documentation of arm inspection on the donor history questionnaire, were…
Jul 3, 2019Class IIIB-0835-2019Red Blood Cells, Leukocytes Reduced
Red Blood Cell product in which Donor Screening/Donor record was incomplete, was distributed.
Jun 28, 2018Class IIB-0018-2019Apheresis Platelets, Leukocytes Reduced and 2 more products
Blood products, collected from an ineligible donor, were distributed.
May 18, 2018Class IIB-0021-2019Red Blood Cells, Leukocytes Reduced and 1 more product
Blood products, collected from an ineligible donor, were distributed.
Sep 13, 2017Class IIB-0272-2018Apheresis Red Blood Cells, Leukocytes Reduced
Blood product, collected from a donor who traveled to a malarial endemic area, was distributed.
Apr 13, 2016Class IIB-0472-16Red Blood Cells, Leukocytes Reduced
Blood Product collected from a donor who traveled to a malarial endemic area was distributed.
Mar 11, 2016Class IIB-0534-16Red Blood Cells, Leukocytes Reduced
Blood product, which was collected from a donor who traveled to malarial endemic areas, was distributed.
Mar 9, 2016Class IIB-0575-16Blood and Blood Products for Reprocessing
Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.
Feb 20, 2015Class IIIB-0899-15Red Blood Cells Leukocytes Reduced
Blood product, collected from a donor who was at risk for leishmaniasis, was distributed.
Sep 4, 2012Class IIB-0313-13Red Blood Cells Leukocytes Reduced and 1 more product
Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob Disease (vCJD), were distributed.

FDA record score

3 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

9 records behind this number
RecordDatePoints x age weightAdds
Class II recall B-0018-2019, this FEI as the recalling firmJun 28, 20184 x 0.251
Class II recall B-0021-2019, this FEI as the recalling firmMay 18, 20184 x 0.251
Class II recall B-0272-2018, this FEI as the recalling firmSep 13, 20174 x 0.251
Class II recall B-0472-16, this FEI as the recalling firmApr 13, 201610 years or older, so it adds no points0
Class II recall B-0534-16, this FEI as the recalling firmMar 11, 201610 years or older, so it adds no points0
Class II recall B-0575-16, this FEI as the recalling firmMar 9, 201610 years or older, so it adds no points0
Class II recall B-0313-13, this FEI as the recalling firmSep 4, 201210 years or older, so it adds no points0
Class II recall B-1789-3, this FEI as the recalling firmApr 30, 200310 years or older, so it adds no points0
Class II recall B-1253-3, this FEI as the recalling firmFeb 6, 200110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing LifeShare Blood Centers as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check LifeShare Blood Centers yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
LifeShare Blood Centers
Location
Lake Charles, LA (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.